Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Multicenter Placebo-Controlled Double-Blind Trial to Evaluate Azidothymidine (AZT) Treatment of the AIDS Dementia Complex and Central Nervous System (CNS) Human Immunodeficiency Virus (HIV) Infection

ClinicalTrials.gov ID: NCT00000702

Public ClinicalTrials.gov record NCT00000702. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 7, 2026, 2:26 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To test whether zidovudine (AZT) is useful as a treatment for the neurologic syndrome called AIDS dementia complex. To determine how long AZT takes to reach cerebral spinal fluid (CSF), how long, and at what concentration it is found there. HIV infection can result in impairment in the function of the brain and spinal cord, leading to disturbances in the ability to think clearly and in strength and coordination. This disorder, which has been called the AIDS dementia complex, may be due to a direct effect of HIV on the nervous system. It is known that AZT does get into the brain to some extent, where it may reduce growth of HIV. It is hoped that AZT will stabilize or improve the symptoms of the AIDS dementia complex.

Study identification

NCT ID
NCT00000702
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
315 participants

Conditions and interventions

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Jul 31, 1990
Last update posted
Nov 2, 2021

Ends 1990

United States locations

U.S. sites
21
U.S. states
8
U.S. cities
14
Facility City State ZIP Site status
UCLA CARE Ctr Los Angeles California 90095
Univ of California / San Diego Treatment Ctr San Diego California 921036325
Stanford Univ School of Medicine Stanford California 94305
Univ of Miami School of Medicine Miami Florida 331361013
Charity Hosp / Tulane Univ Med School New Orleans Louisiana 70112
Louisiana State Univ Med Ctr / Tulane Med School New Orleans Louisiana 70112
Tulane Univ School of Medicine New Orleans Louisiana 70112
Johns Hopkins Hosp Baltimore Maryland 21287
Harvard (Massachusetts Gen Hosp) Boston Massachusetts 02114
Beth Israel Deaconess Med Ctr Boston Massachusetts 02215
SUNY / Erie County Med Ctr at Buffalo Buffalo New York 14215
City Hosp Ctr at Elmhurst / Mount Sinai Hosp Elmhurst New York 11373
Beth Israel Med Ctr / Peter Krueger Clinic New York New York 10003
Bellevue Hosp / New York Univ Med Ctr New York New York 10016
Mem Sloan - Kettering Cancer Ctr New York New York 10021
Mount Sinai Med Ctr New York New York 10029
Univ of Rochester Medical Center Rochester New York 14642
Bronx Municipal Hosp Ctr/Jacobi Med Ctr The Bronx New York 10461
Jack Weiler Hosp / Bronx Municipal Hosp The Bronx New York 10465
Julio Arroyo West Columbia South Carolina 29169
Univ of Washington Seattle Washington 98105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00000702, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 2, 2021 · Synced Sep 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00000702 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →